Contraline

Contraline

Contraline is a company developing contraceptive for men founded by Kevin Eisenfrats.

Contraline has invented a proprietary hydrogel that is implanted into the vas deferens through a minimally invasive, outpatient procedure. The hydrogel works by blocking sperm from traveling through the vas deferens. The vas deferens are a pair of tubes that transport sperm. During a vasectomy, the vas deferens are permanently severed. Rather than cutting the tubes, Echo-VR is a polymer gel that is implanted inside, thus preserving the male reproductive tract. Similar to intrauterine devices (IUDs) for women, Contraline's contraceptive is designed to last for years and be reversible.

Contraline is a medical device company developing a long-lasting, non-hormonal, and reversible male contraceptive using advancements in hydrogel technology. The company was founded in 2015 by Kevin Eisenfrats and Dr. John Herr, and is headquartered in Charlottesville, Virginia. To learn more, visit http://www.contraline.com/.

Timeline

People

Name
Role
LinkedIn

Jaffray Woodriff

Investor

Jean de La Rochebrochard

Investor

Kevin Eisenfrats

Founder

Michael Savino

Investor

Ramtin Naimi

Investor

Surender Punia, MD

Investor

Terry Dougas

Investor

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.